https://www.mdpi.com/2673-5261/2/2/13
Somatic copy number variations (CNV; i.e., amplifications and deletions) have been implicated in the origin and development of multiple cancers and some of...
copy number variationssolid tumorsanalysisusing
https://www.news-medical.net/news/20170505/UAB-spinoff-develops-drug-resistant-immunotherapy-to-combat-solid-tumors.aspx
The University of Alabama at Birmingham and two partner institutions have received a European patent for their novel approach to fighting cancer, an approach...
drug resistantsolid tumorsuabspinoffdevelops
https://www.technologynetworks.com/drug-discovery/news/drug-developed-in-uk-to-treat-solid-tumors-192876
Cancer Research U.K.'s Drug Development Office; Cancer Research Technology, and Lorus Therapeutics Inc. have partnered to take a new therapy with the potential...
u ksolid tumorsdrugdevelopedtreat
https://www.chop.edu/news/new-treatment-shows-success-high-risk-solid-tumors
The CHOP-engineered therapy overcomes common drug resistance and has potential to elicit fewer toxicities than most cancer treatments.
high risksolid tumorsnewtreatmentshows
https://gaia-biomed.com/news/318/
GAIA BioMedicine Inc., a spin-out venture from Kyushu University founded on 2015, is a technology-driven biopharmaceutical company focusing on cellular...
clinical trialamedreleasedsupportgaia